You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 1
  • S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii)

Article metrics

Article menu

Download PDFPDF

S7a – New therapeutic candidates
S7A:5 Sri response, attainment of low disease activity and safety in patients with systemic lupus treated with atacicept in a phase iib study (address ii)
Free

 

Online download statistics by month:

Online download statistics by month: March 2018 to March 2024

AbstractFullPdf
Mar 20181403
Apr 2018201
May 2018803
Jun 2018200
Jul 20181001
Aug 2018402
Sep 2018401
Oct 2018405
Nov 2018204
Dec 20181200
Jan 20192403
Feb 2019600
Mar 20191000
Apr 2019202
May 2019201
Jun 2019201
Jul 20191001
Aug 20191401
Sep 2019400
Oct 2019400
Nov 2019102
Dec 2019701
Jan 2020400
Feb 20201201
Mar 2020400
Apr 20201203
May 20202006
Jun 20201403
Jul 20204004
Aug 2020802
Sep 20201402
Oct 20202808
Nov 20201202
Dec 20201002
Jan 20211204
Feb 2021404
Mar 2021801
Apr 2021002
May 2021002
Jun 2021005
Jul 2021002
Aug 2021002
Sep 2021006
Oct 202114016
Nov 20216013
Dec 2021804
Jan 20221206
Feb 2022701
Mar 20221701
Apr 20221001
May 2022607
Jun 20221803
Jul 20221801
Aug 20222304
Sep 20221007
Oct 20221004
Nov 20221005
Dec 20221000
Jan 20231002
Mar 2023400
Apr 2023301
May 2023002
Jul 2023802
Aug 2023201
Sep 20231204
Oct 2023603
Nov 20231303
Dec 2023600
Jan 20241200
Feb 2024400
Mar 202414075
Total6230259